PTAB Litigation Blog
  • Home
  • Cookie Policy
  • About
  • Advanced Topics
  • Contributors
  • Contacts
  • Design Patents
  • Discovery
  • District Court
  • Joinder
Select Page
Control of IPR Petition Remains Primary Factor in RPI Determination

Control of IPR Petition Remains Primary Factor in RPI Determination

by Matthew Johnson | Jan 28, 2020 | Federal Circuit Appeal, Real Party in Interest

By Robby Breetz and Matt Johnson Determining the Real Party-in-Interest (“RPI”) in an IPR can have critical implications for estoppel.  A patent owner can prevent institution of an IPR by showing that an RPI has previously “filed a civil action challenging the...
Update: Parties, Government Seek Rehearing in Arthrex

Update: Parties, Government Seek Rehearing in Arthrex

by Matthew Johnson | Jan 20, 2020 | Federal Circuit Appeal, PTAB News

By Nate Andrews and Emily Tait – January 17 Update: On January 17, each of the parties filed responses to the rehearing petitions, linked here:  Government Response, Appellant Arthrex’s Response, Appellee Smith & Nephew’s Response As we have...
Update: Parties, Government Seek Rehearing in Arthrex

Parties, Government Seek Rehearing in Arthrex

by Emily Tait | Dec 20, 2019 | Federal Circuit Appeal, PTAB News

By Nate Andrews and Emily Tait – As we have previously discussed on this blog and elsewhere, the Federal Circuit’s decision in Arthrex v. Smith & Nephew has generated significant discussion and controversy in the patent world.  On December 16, both parties...
Timeline of Arthrex Developments

Timeline of Arthrex Developments

by Matthew Johnson | Dec 16, 2019 | Federal Circuit Appeal, PTAB News

By Nate Andrews, Jasper Tran, and Matt Johnson – The Federal Circuit’s decision in Arthrex v. Smith & Nephew excited and disrupted the patent world.  (See, Jones Day Podcast recapping Arthrex decision and fallout.)  Inter partes review (IPR) reshaped patent...
Parties Seek To Preserve Arthrex Rights Despite Waiver Ruling

Parties Seek To Preserve Arthrex Rights Despite Waiver Ruling

by Matthew Johnson | Dec 5, 2019 | Federal Circuit Appeal

By Mike Lavine and Matt Johnson – Following on Judge Newman’s dissent in Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc., parties are seeking to preserve their rights by challenging the Federal Circuit’s holding that a party’s failure to raise the...
Fed. Cir. Dissent: Opening Brief Lacking Appointments Clause Mention Still Eligible for Remand

Fed. Cir. Dissent: Opening Brief Lacking Appointments Clause Mention Still Eligible for Remand

by Tim Heverin | Nov 27, 2019 | Federal Circuit Appeal

By Emma Murray and Tim Heverin Last week, the Federal Circuit denied a motion to vacate and remand an IPR decision under Arthrex, Inc. v. Smith & Nephew, Inc.    Issued on October 31, Arthrex held that the method for appointing PTAB Administrative Patent Judges...
« Older Entries
Next Entries »

About this blog

Categories

  • 325(d) issues
  • Amendment Practice
  • CBMs
  • Claim Construction
  • Design Patents
  • Discovery
  • District Court
  • Estoppel
  • Evidentiary Issues
  • Expert Witnesses
  • Federal Circuit
  • Federal Circuit Appeal
  • Final Written Decisions
  • Joinder
  • Motions Practice
  • Other News
  • Patent Eligible Subject Matter
  • Petitions
  • PGR
  • Pharmaceutical
  • Preliminary Responses
  • Prior Art Issues
  • PTAB News
  • PTAB Trial Basics
  • Real Party in Interest
  • Request for Reconsideration
  • Standing
  • Stay
  • Time Limits
  • Trial Institution
  • Uncategorized

Archives

Links

www.jonesday.com

About Jones Day's Intellectual Property Practice

Subscribe to Jones Day publications

    • Privacy
    • X
    • RSS

    The opinions expressed are those of the authors and do not necessarily reflect the views of Jones Day or its clients. The posts and information provided are for general information purposes and are not intended to be and should not be taken as legal advice.